Adults at risk of hepatitis A and hepatitis B have multi-dose vaccinations available, but complete and timely vaccination adherence rates are low. What can be done to encourage more vaccine adherence?
Investigators estimated the incidence of HBsAg seroclearance in patients with hepatitis B virus infection on long-term therapy with entecavir or tenofovir disoproxil fumarate.
While the risk is small, there have been 20 cases of unexpected donor-derived hepatitis B virus infection
Findings emphasize the importance of strategies to help HBV-HIV coinfected patients maximize antiretroviral adherence to achieve hepatitis B viral suppression.
Vaxelis is the first hexavalent combination vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.
The finding of a reduce risk of cirrhosis in patients with chronic HBV on antiviral therapy underscores the importance of early treatment.
Investigators analyzed the safety of tenofovir disoproxil fumarate therapy during the third trimester of pregnancy.
Researchers aimed to characterize serological, virological, and histological profiles during and after multidose ARC-520 treatment in patients with chronic HBV.
Studies have demonstrated an association between direct-acting antiviral therapy and a reduction in both the incidence and severity of extrahepatic manifestations of HCV.
Patients with current or past HBV infection are not at greater risk for liver injury or mortality during COVID-19 infection.
